Lifestyle NeoVax Plus Nivolumab: Early Trial Tests Personalised Ovarian VaccineLouis MartinOctober 16, 2026 A phase 1 Nature Medicine trial reports that NeoVax, a vaccine built from each patient’s tumour mutations, could be combined safely with nivolumab in ovarian cancer.
